Nab-paclitaxel trials for TNBC - Triple-Negative Breast Cancer

All Nab-paclitaxel trials · All TNBC - Triple-Negative Breast Cancer trials

Phase breakdown

Recruiting trials studying Nab-paclitaxel for TNBC - Triple-Negative Breast Cancer

• A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC
  NCT07178171 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast Cancer
  NCT06387628 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBC
  NCT06786026 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location

Common questions

How many trials study Nab-paclitaxel for TNBC - Triple-Negative Breast Cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.